Avanos Medical (AVNS) Earnings Analysis
Avanos Medical (AVNS) has no confirmed upcoming earnings date. Last quarter (2025-02-26) it beat with EPS 0.43 USD vs 0.4 USD est (+7.5%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -16.65.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AVNS next report earnings?
No confirmed upcoming earnings date is currently scheduled for AVNS. This page updates as the calendar is published.
AVNS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-02-26 | 0.43 USD | 0.4 USD | +7.5% | Beat |
| 2024-10-30 | 0.36 USD | 0.36 USD | 0% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
AVNS valuation and analyst view
| Trailing P/E | -16.65 |
|---|---|
| Trailing EPS | -1.49569 USD |
| Price / book | 1.48 |
| Dividend yield | 0.00% |
| Market cap | 1.17B |
| Analyst consensus | Hold (1 buy / 6 hold / 1 sell) |
Related research pages
Frequently asked questions
When is Avanos Medical (AVNS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AVNS. This page updates as the calendar is published.
Did AVNS beat earnings last quarter?
In its 2025-02-26 report, AVNS posted EPS of 0.43 USD versus a 0.4 USD estimate — a beat of 7.5%.
What is AVNS's earnings track record?
Over the last 2 reported quarters with consensus data, AVNS beat estimates 2 times (100%).
What is AVNS's current P/E ratio and EPS?
AVNS trades at a trailing P/E of -16.65 on trailing EPS of -1.4956896551724137 USD.
What do analysts rate AVNS?
Analyst consensus is "Hold" across 8 ratings (0 strong buy, 1 buy, 6 hold, 1 sell, 0 strong sell).